Therapeutic Concern: HSV-2 Resistance Following Long-Term Antiviral Use

Authors

Farzane Behnezhad (ORCID: https://orcid.org/0000-0003-4648-9617)
Akram Astani (ORCID: https://orcid.org/0000-0002-6915-1320)

Institutions

Iran University of Medical Sciences (IR)
Shahid Sadoughi University of Medical Sciences and Health Services (IR)

Publication Details

Journal: Advances in Pharmacology and Therapeutics Journal
Published: 2025-08-31
DOI: https://doi.org/10.18502/aptj.v5i2.19460
Primary Topic: Herpesvirus Infections and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Therapeutic Concern: HSV-2 Resistance Following Long-Term Antiviral Use

Farzane Behnezhad, Akram Astani

Aug 31, 2025

Advances in Pharmacology and Therapeutics Journal

Herpesvirus Infections and Treatments

article

Therapeutic Concern: HSV-2 Resistance Following Long-Term Antiviral Use

Farzane Behnezhad, Akram Astani

August 31, 2025article en

Abstract

No abstract available for this paper.

Advances in Pharmacology and Therapeutics Journal

Iran University of Medical Sciences (IR), Shahid Sadoughi University of Medical Sciences and Health Services (IR)

Openalex Percentile: Top 69%

Herpesvirus Infections and Treatments

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Therapeutic Concern: HSV-2 Resistance Following Long-Term Antiviral Use — Farzane Behnezhad, Akram Astani · Advances in Pharmacology and Therapeutics Journal (2025) | TGRS Research Map | TGRS